BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261118T183000
DTEND;TZID=America/Halifax:20261118T183000
DTSTAMP:20260905T151650Z
CREATED:20260905T151650Z
LAST-MODIFIED:20260905T151650Z
UID:10000996-1795026600-1795026600@oncodaily.com
SUMMARY:ESMO Deep Dive: Are We Defeating Cervical Cancer?
DESCRIPTION:The ESMO Deep Dive: Gynaecological Cancers – Are We Defeating Cervical Cancer? 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 18\, 2026\, at 6:30 PM CET (9:30 PM AMT) as a live virtual webinar. \nThe session will review recent progress and remaining challenges in cervical cancer management\, including pembrolizumab combined with concurrent chemoradiation for locally advanced disease\, the role of immune checkpoint inhibitors in recurrent or metastatic cervical cancer\, and treatment options after progression on immunotherapy. \nThe expert discussion will examine how these developments are changing clinical practice and what questions remain as systemic treatment strategies continue to evolve. Participants attending the live session can earn 2 ESMO-MORA Category 1 points.
URL:https://oncodaily.com/event/esmo-deep-dive-581188
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-5-2026-07_13_26-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261125
DTEND;VALUE=DATE:20261127
DTSTAMP:20260903T202512Z
CREATED:20260903T202437Z
LAST-MODIFIED:20260903T202512Z
UID:10000992-1795564800-1795737599@oncodaily.com
SUMMARY:ESMO Advanced Course on Endocrine Sensitivity in HR+/HER2− Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Defining Endocrine Sensitivity & Optimising Treatment Strategies in HR+/HER2− mBC Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 25\, 2026\, in Barcelona\, Spain. \nThe course will focus on the increasingly complex management of hormone receptor-positive\, HER2-negative metastatic breast cancer\, particularly how clinicians define endocrine sensitivity and resistance and use these distinctions to guide treatment decisions. \nThe programme is designed to support evidence-based therapeutic selection and sequencing as treatment options for HR+/HER2− metastatic disease continue to expand\, with emphasis on integrating clinical and molecular information into individualized patient management.
URL:https://oncodaily.com/event/endocrine-sensitivity-580276
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-4-2026-12_22_08-AM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261127
DTEND;VALUE=DATE:20261128
DTSTAMP:20260826T141815Z
CREATED:20260826T141815Z
LAST-MODIFIED:20260826T141815Z
UID:10000962-1795737600-1795823999@oncodaily.com
SUMMARY:The Best of ESMO Baltic 2026 Conference
DESCRIPTION:The Best of ESMO Baltic 2026 conference will take place on November 27\, 2026\, in Riga\, Latvia\, bringing together oncology specialists from Latvia\, Estonia\, Lithuania\, and other countries to review key findings and clinical highlights from the latest ESMO Congress. \nThe programme will focus on translating important new evidence into everyday oncology practice through expert presentations\, discussion\, and exchange of experience among regional and international specialists. \nThe meeting is primarily intended for oncologists and chemotherapy specialists and can be attended either in person or remotely. All participants will receive an 8-hour qualification certificate. The conference is organized by the Latvian Association of Oncologist Chemotherapists\, in close collaboration with the relevant Estonian and Lithuanian societies.
URL:https://oncodaily.com/event/esmo-baltic-2026-conference-575045
LOCATION:Radisson Blu Latvija Conference & Spa Hotel\, Elizabetes iela 55\, Riga\, Riga\, LV-1010\, Latvia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ESMO2026_1200x628-1-03a0716d-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261207
DTSTAMP:20260105T000508Z
CREATED:20260105T000502Z
LAST-MODIFIED:20260105T000508Z
UID:10000552-1796342400-1796601599@oncodaily.com
SUMMARY:ESMO Asia Congress 2026
DESCRIPTION:The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals\, scheduled for December 4-6\, 2026\, in Singapore. \nOrganized by the European Society for Medical Oncology (ESMO)\, this major international congress brings together global experts and regional leaders to present the latest research and clinical data across all major tumor types. \nThe technical program features high-level scientific symposia\, educational sessions on state-of-the-art treatments\, and a dedicated Young Oncologists track aimed at fostering the next generation of cancer researchers. The event emphasizes regional specificities in cancer management and promotes collaborative research to improve patient outcomes throughout Asia.
URL:https://oncodaily.com/event/esmo-asia-436785
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard Singapore\, Singapore\, 039593\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Asia-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261214
DTEND;VALUE=DATE:20261217
DTSTAMP:20251211T194040Z
CREATED:20251211T193956Z
LAST-MODIFIED:20251211T194040Z
UID:10000476-1797206400-1797465599@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2026
DESCRIPTION:The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO)\, scheduled for December 14–16\, 2026\, as an onsite event in London\, United Kingdom\, with an online option also available. \nThe congress serves as a critical platform for exchanging knowledge and fostering collaboration in immuno-oncology\, covering the entire spectrum of the field from basic science to translational research and clinical development. The meeting will feature the latest scientific advances\, offering researchers\, clinicians\, and other stakeholders excellent opportunities to interact\, share expertise\, and engage with the global community committed to advancing cancer care through innovation.
URL:https://oncodaily.com/event/immuno-oncology-426416
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-IO-2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270113
DTEND;VALUE=DATE:20270115
DTSTAMP:20260905T150053Z
CREATED:20260905T150053Z
LAST-MODIFIED:20260905T150053Z
UID:10000995-1799798400-1799971199@oncodaily.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2027
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on January 13–14\, 2027\, in Hong Kong SAR\, China. \nThe two-day educational course will provide a multidisciplinary update on the management of prostate cancer\, covering the disease continuum from diagnosis and risk assessment through localized and advanced disease. \nESMO prostate cancer preceptorships are structured around current standards of care\, multidisciplinary decision-making\, systemic and local treatment strategies\, emerging therapeutic targets\, and future perspectives\, combining expert lectures with practical clinical discussion. The meeting takes place immediately before the inaugural ESMO Genitourinary Cancers Asia 2027\, which begins in Hong Kong on January 15.
URL:https://oncodaily.com/event/preceptorship-on-prostate-cancer-581173
LOCATION:Hong Kong\, Hong Kong\, Hong Kong SAR\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-5-2026-06_58_44-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270118
DTSTAMP:20260826T143152Z
CREATED:20260826T143152Z
LAST-MODIFIED:20260826T143152Z
UID:10000963-1799971200-1800230399@oncodaily.com
SUMMARY:The Inaugural ESMO Genitourinary Cancers Asia 2027
DESCRIPTION:The Inaugural ESMO Genitourinary Cancers Asia 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on January 15–17\, 2027\, at the Kerry Hotel Hong Kong in Hong Kong SAR\, China. \nThe new congress is dedicated to advancing genitourinary oncology across the Asia-Pacific region\, bringing together regional and international experts for multidisciplinary discussion and presentation of practice-changing research. \nThe scientific programme will cover prostate\, bladder\, kidney\, testicular\, and other genitourinary cancers\, with a focus on clinically relevant evidence\, regional perspectives\, research collaboration\, and innovation in GU cancer care. Abstract submission is open until October 13\, 2026\, and registration is now open\, with the early registration deadline on November 11\, 2026.
URL:https://oncodaily.com/event/esmo-genitourinary-cancers-asia-575063
LOCATION:Kerry Hotel Hong Kong\, 38 Hung Luen Road\, Hung Hom Bay\, Kowloon\, Hong Kong\, Kowloon\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-06_31_15-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270222
DTEND;VALUE=DATE:20270225
DTSTAMP:20260923T123621Z
CREATED:20260923T123544Z
LAST-MODIFIED:20260923T123621Z
UID:10001062-1803254400-1803513599@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies (TAT) Congress 2027
DESCRIPTION:The ESMO Targeted Anticancer Therapies (TAT) Congress 2027 will take place from February 22–24\, 2027\, at the Palais des Congrès de Paris in Paris\, France. \nOrganized by the European Society for Medical Oncology (ESMO)\, the congress will bring together clinicians\, researchers\, and experts in drug development to discuss advances in early-phase oncology research and innovative anticancer therapies. \nThe meeting will focus on the development and clinical translation of targeted anticancer therapies\, including molecularly driven drug development\, precision oncology approaches\, biomarkers\, early clinical trials\, and emerging treatment strategies. The congress provides a platform for researchers\, clinicians\, and industry experts to exchange knowledge on new therapeutic approaches and their path from discovery to patient care.
URL:https://oncodaily.com/event/targeted-anticancer-therapies-591846
LOCATION:Palais des Congrès de Paris\, 2 Pl de la Pte Maillot\, Paris\, Île-de-France\, 75017\, France
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-23-2026-04_34_52-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270308
DTEND;VALUE=DATE:20270311
DTSTAMP:20260822T124507Z
CREATED:20260822T124507Z
LAST-MODIFIED:20260822T124507Z
UID:10000939-1804464000-1804723199@oncodaily.com
SUMMARY:The ESMO Novel Cancer Therapies 2027
DESCRIPTION:The ESMO Novel Cancer Therapies 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on March 8–10\, 2027\, in Lugano\, Switzerland. \nThis new ESMO meeting is designed for multidisciplinary oncology professionals and will focus on how approved novel cancer therapies can be translated into everyday clinical practice\, with particular attention to treatment selection\, practical implementation\, toxicity prevention and management\, and optimizing patient outcomes. \nThe programme will combine expert presentations\, multidisciplinary discussions\, real-world clinical cases\, and peer-to-peer learning. Day 1 will feature a major focus on antibody-drug conjugates (ADCs)\, including their clinical use\, supportive care considerations\, management of ADC-related toxicities\, and practical issues around combinations and treatment sequencing. \nAccess the online programme.
URL:https://oncodaily.com/event/esmo-novel-cancer-therapies-572176
LOCATION:Lugano\, Lugano\, Ticino\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270317
DTEND;VALUE=DATE:20270321
DTSTAMP:20260825T230738Z
CREATED:20260825T230738Z
LAST-MODIFIED:20260825T230738Z
UID:10000953-1805241600-1805587199@oncodaily.com
SUMMARY:The European Lung Cancer Congress 2027
DESCRIPTION:The European Lung Cancer Congress 2027 (ELCC 2027) will take place on March 17–20\, 2027\, in Munich\, Germany\, with both onsite and online participation. \nThe congress is jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) and brings together the multidisciplinary thoracic oncology community to advance science\, share education\, and improve clinical practice for patients with lung and other thoracic cancers. \nThe programme is designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians and pneumologists\, interventional radiologists\, pathologists\, and other professionals involved in thoracic cancer care\, with an emphasis on cross-specialty discussion\, emerging evidence\, and practical take-home insights that can inform everyday patient management.
URL:https://oncodaily.com/event/european-lung-cancer-congress-574706
LOCATION:ICM – International Congress Center Messe München\, Am Messesee 2\, Munich\, Bavaria\, 81829\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-03_05_49-AM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270615
DTEND;VALUE=DATE:20270620
DTSTAMP:20261017T150143Z
CREATED:20261017T150143Z
LAST-MODIFIED:20261017T150143Z
UID:10001114-1813017600-1813449599@oncodaily.com
SUMMARY:19th International Conference on Malignant Lymphoma (ICML 2027)
DESCRIPTION:The 19th International Conference on Malignant Lymphoma (ICML 2027) will take place from June 15–19\, 2027\, at Palazzo dei Congressi in Lugano\, Switzerland. \nThe international congress is dedicated to advancing research and treatment in malignant lymphomas\, bringing together physicians\, scientists\, and multidisciplinary specialists from around the world. The 2027 edition is expected to provide a comprehensive scientific programme covering the latest developments in lymphoma biology\, diagnosis\, treatment\, and translational research. \nICML is a major international meeting in the field of lymphoid neoplasms\, offering a platform for the presentation of new clinical and scientific data and discussion of emerging therapeutic approaches. The programme traditionally combines keynote lectures\, plenary sessions\, educational sessions\, clinical case discussions\, scientific presentations\, poster sessions\, and opportunities for interaction with international experts. \nThe 2027 meeting will also feature the ICML-ESMO Full-immersion Course\, scheduled for June 12–14\, 2027\, immediately preceding the main congress and offering focused education on malignant lymphoma.
URL:https://oncodaily.com/event/malignant-lymphoma-610469
LOCATION:Palazzo dei Congressi Lugano\, Piazza dell'Indipendenza 4\, Lugano\, Canton of Ticino\, 6900\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/ff613adbdb817221eaf9c1210e734a9a.webp
ORGANIZER;CN="Foundation for the Institute of Oncology Research":MAILTO:info@ior.usi.ch
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270917
DTEND;VALUE=DATE:20270922
DTSTAMP:20251127T194628Z
CREATED:20251127T194612Z
LAST-MODIFIED:20251127T194628Z
UID:10000413-1821139200-1821571199@oncodaily.com
SUMMARY:ESMO Congress 2027
DESCRIPTION:The ESMO Congress 2027 will take place in Barcelona\, Spain\, from September 17–21\, 2027. \nThis event is recognized as a leading global oncology meeting that serves as a platform for progress by showcasing the latest breakthroughs in oncology research\, clinical practice\, and patient care. The congress brings together a diverse community\, including clinicians\, researchers\, patient advocates\, journalists\, and healthcare industry representatives. \nParticipants can anticipate a dynamic program featuring: \n\nImpactful new data from oncology research.\nInteractive educational sessions.\nUnique networking opportunities.\nA dynamic exhibition area.\n\nBy attending\, participants will gain first-hand insights into the most recent advances and contribute to shaping the future of oncology worldwide.
URL:https://oncodaily.com/event/esmo-congress-2027-417485
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR